NEW YORK (GenomeWeb News) – GenOway, a French firm that develops transgenic mice and rats, began trading on Euronext’s Alternext exchange on April 5, the company said this week.
 
The company raised €27.7 million ($37.4 million) in its initial public offering, trading 5.6 million shares at €4.96 per share.
 
The company’s shares are trading at €6 today.
 
The Alternext, which opened two years ago, is a Euronext market designed for small and mid-cap companies.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.